M. YILDIZ Et Al. , "Effect of Tocilizumab Therapy On Patient Outcome In Severe COVID-19 Pneumonia," Infectious diseases and clinical microbiology (Online) , vol.3, no.2, pp.55-63, 2021
YILDIZ, M. Et Al. 2021. Effect of Tocilizumab Therapy On Patient Outcome In Severe COVID-19 Pneumonia. Infectious diseases and clinical microbiology (Online) , vol.3, no.2 , 55-63.
YILDIZ, M., SULTANOVA, F., ÖZGER, H. S., BÜYÜKKÖRÜK, M., ERBAY, K., GAYGUSUZ, Ü., ... TUFAN, A.(2021). Effect of Tocilizumab Therapy On Patient Outcome In Severe COVID-19 Pneumonia. Infectious diseases and clinical microbiology (Online) , vol.3, no.2, 55-63.
YILDIZ, MEHMET Et Al. "Effect of Tocilizumab Therapy On Patient Outcome In Severe COVID-19 Pneumonia," Infectious diseases and clinical microbiology (Online) , vol.3, no.2, 55-63, 2021
YILDIZ, MEHMET Et Al. "Effect of Tocilizumab Therapy On Patient Outcome In Severe COVID-19 Pneumonia." Infectious diseases and clinical microbiology (Online) , vol.3, no.2, pp.55-63, 2021
YILDIZ, M. Et Al. (2021) . "Effect of Tocilizumab Therapy On Patient Outcome In Severe COVID-19 Pneumonia." Infectious diseases and clinical microbiology (Online) , vol.3, no.2, pp.55-63.
@article{article, author={MEHMET YILDIZ Et Al. }, title={Effect of Tocilizumab Therapy On Patient Outcome In Severe COVID-19 Pneumonia}, journal={Infectious diseases and clinical microbiology (Online)}, year=2021, pages={55-63} }